Dr. Daniel L. Feiler, M.D.
Ophthalmology (Ophthalmology Physician)
- Medicare participating
At a glance
- Medical school
- University of Rochester School of Medicine and Dentistry (2013)
- Years since graduation
- 13
- In the NPI registry since
- 2013
- Medicare patients seen, 2024
- 1,617
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. What an NPI is
Education and training
- 2013Medical school: University of Rochester School of Medicine and Dentistry
- 2013Registered with an NPI (national billing number; not a license date)
Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Ophthalmology Physician primary
KS license 04-41934 · IA license MD-44129 · MO license 2019008671 -
Retina Specialist (Ophthalmology) Physician
IA license MD-44129 · KS license 04-41934 · MO license 2019008671
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Where they work
Hospitals
- Adventhealth Shawnee Mission Shawnee Mission, KS
Medical groups
- Retina Associates LLC (12 clinicians)
Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.
Medicare patients and services
- Medicare patients, 2024
- 1,617
- Services billed
- 43,617
- Patients’ average age
- 77
| Service | Times | Patients |
|---|---|---|
| Injection, faricimab-svoa, 0.1 mg | 12,660 | 31 |
| Injection, aflibercept, 1 mg | 5,134 | 453 |
| Imaging of retina | 3,476 | 1,134 |
| Injection of drug into eye | 2,577 | 565 |
| Established patient complete exam of visual system | 1,154 | 786 |
| Photography of the retina | 818 | 633 |
| Injection, dexamethasone, intravitreal implant, 0.1 mg | 721 | 38 |
| Injection, ranibizumab, 0.1 mg | 585 | 25 |
| Exam of retinal blood vessels using a special camera after injection of a dye | 304 | 276 |
| Established patient office or other outpatient visit, 30-39 minutes | 297 | 245 |
Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.
Medicare prescriptions
| Drug | Prescriptions |
|---|---|
| Prednisolone Acetate Other prescribers in Lenexa, KS | 142 |
| Ofloxacin Other prescribers in Lenexa, KS | 97 |
| Dorzolamide-Timolol (dorzolamide hcl/timolol maleat) Other prescribers in Lenexa, KS | 52 |
| Difluprednate | 44 |
| Timolol Maleate Other prescribers in Lenexa, KS | 32 |
| Brimonidine Tartrate Other prescribers in Lenexa, KS | 19 |
| Latanoprost Other prescribers in Lenexa, KS | 14 |
| Atropine Sulfate | 12 |
| Moxifloxacin (moxifloxacin hcl) Other prescribers in Lenexa, KS | 11 |
Prescriptions filled under Medicare Part D, including refills. CMS leaves out drugs prescribed fewer than 11 times.
Payments from drug and device companies
In 2025, 7 companies reported 36 payments worth $1,130 in total to this clinician.
| Ani Pharmaceuticals, Inc. | $405 |
|---|---|
| Regeneron Healthcare Solutions, Inc. | $255 |
| Apellis Pharmaceuticals, Inc. | $228 |
| AbbVie Inc. | $149 |
| Astellas Pharma US Inc | $47.06 |
| Genentech USA, Inc. | $24.74 |
| Harrow Eye, LLC | $20.79 |
| Food and Beverage | $1,130 |
|---|
From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.